Global Ocular Drug Delivery Market Size study & Forecast, by Technology (Topical, Iontophoresis, Ocular Insert, Intraocular Implants, In Situ Gel Punctal Plugs, Others), by Formulation Type (Liposomes Nanoparticles, Solution, Emulsion, Suspension, Ointment), by Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Others) and by End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Homecare Settings) and Regional Analysis, 2023-2030
Global Ocular Drug Delivery Market is valued approximately USD xxx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xxx over the forecast period 2023-2030. Ocular Drug Delivery refers to a dosage form, vehicle, or system used to give or transport medication to the eye for the treatment of any condition that involves or affects vision. The eye is a very important organ that is susceptible to several illnesses. In addition to having an impact on the body, many eye conditions can cause blindness. It varies from straightforward implants for intraocular tissue to basic sterile eye drops for the ocular surface. The major factors driving the growth of the global ocular drug delivery technology market are low bioavailability of drugs in conventional ocular therapies, an increase in the incidence of glaucoma and macular degeneration, growing demand for targeted ocular drug delivery techniques, and an increase in the number of approvals from government regulations for new ocular drug delivery techniques. Favourable reimbursement policies and increased investment for the development of innovative drug delivery systems can assist drive market expansion.
Growing need for tailored ocular medicine delivery systems due to rise in glaucoma and macular degeneration rates. According to the World Health Organization in 2020, after cataract (35.2%) and uncorrected refractive error (20.3%), glaucoma is the third greatest cause of blindness (8.5%). According to estimate, 2.9 million individuals are blind from glaucoma, and 4 million people have some form of visual impairment. In the worldwide pool of vision loss, it was projected that the numbers would rise to 4.5 million for visual impairment and 3.2 million for blindness by 2020, respectively. Another recent systematic analysis reveals that glaucoma affects roughly 64 million individuals globally between the ages of 40 and 80, with that number anticipated to rise to 76 million by the year 2020. Additionally, the use of ocular penetration enhancers such as para-cellular pathways and phase transitions systems and the protective barrier systems of the human eye impede medication delivery effectiveness is projected to expand the market for ocular drug delivery systems. However, the high cost of production and drug related side effects stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Ocular Drug Delivery Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to availability of highly developed products and skilled professionals, growing governmental emphasis on R&D operations, well-established infrastructure for healthcare and research. Additionally, it is projected that an increase in the frequency of eye problems in this area would promote regional growth. Asia Pacific is expected to grow significantly during the forecast period, owing to the establishment of R&D facilities by prominent manufacturers in emerging nations, increasing prevalence of eye diseases, growing geriatric population, increasing healthcare expenditure, and favorable regulatory environment in the region.
Major market player included in this report are:
Valeant Pharmaceuticals International, Inc.
Taiwan Liposome Company, Ltd.
Ocular Therapeutix, Inc.
Graybug Vision Inc.
EyeGate Pharma
Clearside Biomedical, Inc.
Alimera Sciences
Envisia Therapeutics
Allergan, Plc.
AbbVie Inc.
Recent Developments in the Market:
In February 2022, Alimera Sciences Europe Limited, its Irish-based European subsidiary, has launched ILUVIEN for non-infectious posterior uveitis in Spain through its distribution partner, Brill Pharma (Brill). Alimera Sciences, Inc. is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with maintaining better vision longer.
In October 2021, Allergan, an Abbie company, announced that it will present new pooled analyses and post-hoc results from the Phase 3 trials of AGN-190584 (pilocarpine HCI ophthalmic solution 1.25%), an investigational novel treatment for presbyopia, at Academy 2021, the American Academy of Optometry's annual meeting, which will be held November 3-6. Clinical data for near and intermediate vision, functional near vision, effectiveness for post-LASIK patients, and patient experience were all presented.
Global Ocular Drug Delivery Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Technology, Formulation Type, Disease Type, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Topical
Iontophoresis
Ocular Insert
Intraocular Implants
In Situ Gel Punctal Plugs
Others
By Formulation Type
Liposomes Nanoparticles
Solution
Emulsion
Suspension
Ointment
By Disease Type:
Glaucoma
Diabetic Retinopathy
Dry Eye Syndrome
Macular Degeneration
Cataract
Others
By End User:
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
Homecare Settings
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Growing need for tailored ocular medicine delivery systems due to rise in glaucoma and macular degeneration rates. According to the World Health Organization in 2020, after cataract (35.2%) and uncorrected refractive error (20.3%), glaucoma is the third greatest cause of blindness (8.5%). According to estimate, 2.9 million individuals are blind from glaucoma, and 4 million people have some form of visual impairment. In the worldwide pool of vision loss, it was projected that the numbers would rise to 4.5 million for visual impairment and 3.2 million for blindness by 2020, respectively. Another recent systematic analysis reveals that glaucoma affects roughly 64 million individuals globally between the ages of 40 and 80, with that number anticipated to rise to 76 million by the year 2020. Additionally, the use of ocular penetration enhancers such as para-cellular pathways and phase transitions systems and the protective barrier systems of the human eye impede medication delivery effectiveness is projected to expand the market for ocular drug delivery systems. However, the high cost of production and drug related side effects stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Ocular Drug Delivery Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to availability of highly developed products and skilled professionals, growing governmental emphasis on R&D operations, well-established infrastructure for healthcare and research. Additionally, it is projected that an increase in the frequency of eye problems in this area would promote regional growth. Asia Pacific is expected to grow significantly during the forecast period, owing to the establishment of R&D facilities by prominent manufacturers in emerging nations, increasing prevalence of eye diseases, growing geriatric population, increasing healthcare expenditure, and favorable regulatory environment in the region.
Major market player included in this report are:
Valeant Pharmaceuticals International, Inc.
Taiwan Liposome Company, Ltd.
Ocular Therapeutix, Inc.
Graybug Vision Inc.
EyeGate Pharma
Clearside Biomedical, Inc.
Alimera Sciences
Envisia Therapeutics
Allergan, Plc.
AbbVie Inc.
Recent Developments in the Market:
In February 2022, Alimera Sciences Europe Limited, its Irish-based European subsidiary, has launched ILUVIEN for non-infectious posterior uveitis in Spain through its distribution partner, Brill Pharma (Brill). Alimera Sciences, Inc. is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with maintaining better vision longer.
In October 2021, Allergan, an Abbie company, announced that it will present new pooled analyses and post-hoc results from the Phase 3 trials of AGN-190584 (pilocarpine HCI ophthalmic solution 1.25%), an investigational novel treatment for presbyopia, at Academy 2021, the American Academy of Optometry's annual meeting, which will be held November 3-6. Clinical data for near and intermediate vision, functional near vision, effectiveness for post-LASIK patients, and patient experience were all presented.
Global Ocular Drug Delivery Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Technology, Formulation Type, Disease Type, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Topical
Iontophoresis
Ocular Insert
Intraocular Implants
In Situ Gel Punctal Plugs
Others
By Formulation Type
Liposomes Nanoparticles
Solution
Emulsion
Suspension
Ointment
By Disease Type:
Glaucoma
Diabetic Retinopathy
Dry Eye Syndrome
Macular Degeneration
Cataract
Others
By End User:
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
Homecare Settings
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Ocular Drug Delivery Market, by region, 2020-2030 (USD Billion)
1.2.2. Ocular Drug Delivery Market, by Technology, 2020-2030 (USD Billion)
1.2.3. Ocular Drug Delivery Market, by Formulation Type, 2020-2030 (USD Billion)
1.2.4. Ocular Drug Delivery Market, by Disease Type, 2020-2030 (USD Billion)
1.2.5. Ocular Drug Delivery Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OCULAR DRUG DELIVERY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OCULAR DRUG DELIVERY MARKET DYNAMICS
3.1. Ocular Drug Delivery Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of glaucoma and macular degeneration
3.1.1.2. Approvals from government regulations for new ocular drug delivery techniques.
3.1.2. Market Challenges
3.1.2.1. High production cost of ocular drug delivery
3.1.2.2. Drug related side effects
3.1.3. Market Opportunities
3.1.3.1. Advancements in the use of ocular penetration enhancers
3.1.3.2. Protective barrier systems of the human eye impede medication delivery effectiveness
CHAPTER 4. GLOBAL OCULAR DRUG DELIVERY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL OCULAR DRUG DELIVERY MARKET, BY TECHNOLOGY
5.1. Market Snapshot
5.2. Global Ocular Drug Delivery Market by Technology, Performance - Potential Analysis
5.3. Global Ocular Drug Delivery Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
5.4. Ocular Drug Delivery Market, Sub Segment Analysis
5.4.1. Topical
5.4.2. Iontophoresis
5.4.3. Ocular Insert
5.4.4. Intraocular Implants
5.4.5. In Situ Gel Punctal Plugs
5.4.6. Others
CHAPTER 6. GLOBAL OCULAR DRUG DELIVERY MARKET, BY FORMULATION TYPE
6.1. Market Snapshot
6.2. Global Ocular Drug Delivery Market by Formulation Type, Performance - Potential Analysis
6.3. Global Ocular Drug Delivery Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
6.4. Ocular Drug Delivery Market, Sub Segment Analysis
6.4.1. Liposomes & Nanoparticles
6.4.2. Solution
6.4.3. Emulsion
6.4.4. Suspension
6.4.5. Ointment
CHAPTER 7. GLOBAL OCULAR DRUG DELIVERY MARKET, BY DISEASE TYPE
7.1. Market Snapshot
7.2. Global Ocular Drug Delivery Market by Disease Type, Performance - Potential Analysis
7.3. Global Ocular Drug Delivery Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
7.4. Ocular Drug Delivery Market, Sub Segment Analysis
7.4.1. Glaucoma
7.4.2. Diabetic Retinopathy
7.4.3. Dry Eye Syndrome
7.4.4. Macular Degeneration
7.4.5. Cataract
7.4.6. Others
CHAPTER 8. GLOBAL OCULAR DRUG DELIVERY MARKET, BY END USER
8.1. Market Snapshot
8.2. Global Ocular Drug Delivery Market by End User, Performance - Potential Analysis
8.3. Global Ocular Drug Delivery Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
8.4. Ocular Drug Delivery Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Ophthalmic Clinics
8.4.3. Ambulatory Surgical Centers
8.4.4. Homecare Settings
CHAPTER 9. GLOBAL OCULAR DRUG DELIVERY MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Ocular Drug Delivery Market, Regional Market Snapshot
9.4. North America Ocular Drug Delivery Market
9.4.1. U.S. Ocular Drug Delivery Market
9.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.2. Formulation Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Disease Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Ocular Drug Delivery Market
9.5. Europe Ocular Drug Delivery Market Snapshot
9.5.1. U.K. Ocular Drug Delivery Market
9.5.2. Germany Ocular Drug Delivery Market
9.5.3. France Ocular Drug Delivery Market
9.5.4. Spain Ocular Drug Delivery Market
9.5.5. Italy Ocular Drug Delivery Market
9.5.6. Rest of Europe Ocular Drug Delivery Market
9.6. Asia-Pacific Ocular Drug Delivery Market Snapshot
9.6.1. China Ocular Drug Delivery Market
9.6.2. India Ocular Drug Delivery Market
9.6.3. Japan Ocular Drug Delivery Market
9.6.4. Australia Ocular Drug Delivery Market
9.6.5. South Korea Ocular Drug Delivery Market
9.6.6. Rest of Asia Pacific Ocular Drug Delivery Market
9.7. Latin America Ocular Drug Delivery Market Snapshot
9.7.1. Brazil Ocular Drug Delivery Market
9.7.2. Mexico Ocular Drug Delivery Market
9.8. Middle East & Africa Ocular Drug Delivery Market
9.8.1. Saudi Arabia Ocular Drug Delivery Market
9.8.2. South Africa Ocular Drug Delivery Market
9.8.3. Rest of Middle East & Africa Ocular Drug Delivery Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Valeant Pharmaceuticals International, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Taiwan Liposome Company, Ltd.
10.3.3. Ocular Therapeutix, Inc.
10.3.4. Graybug Vision Inc.
10.3.5. EyeGate Pharma
10.3.6. Clearside Biomedical, Inc.
10.3.7. Alimera Sciences
10.3.8. Envisia Therapeutics
10.3.9. Allergan, Plc.
10.3.10. AbbVie Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Ocular Drug Delivery Market, by region, 2020-2030 (USD Billion)
1.2.2. Ocular Drug Delivery Market, by Technology, 2020-2030 (USD Billion)
1.2.3. Ocular Drug Delivery Market, by Formulation Type, 2020-2030 (USD Billion)
1.2.4. Ocular Drug Delivery Market, by Disease Type, 2020-2030 (USD Billion)
1.2.5. Ocular Drug Delivery Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OCULAR DRUG DELIVERY MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OCULAR DRUG DELIVERY MARKET DYNAMICS
3.1. Ocular Drug Delivery Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of glaucoma and macular degeneration
3.1.1.2. Approvals from government regulations for new ocular drug delivery techniques.
3.1.2. Market Challenges
3.1.2.1. High production cost of ocular drug delivery
3.1.2.2. Drug related side effects
3.1.3. Market Opportunities
3.1.3.1. Advancements in the use of ocular penetration enhancers
3.1.3.2. Protective barrier systems of the human eye impede medication delivery effectiveness
CHAPTER 4. GLOBAL OCULAR DRUG DELIVERY MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL OCULAR DRUG DELIVERY MARKET, BY TECHNOLOGY
5.1. Market Snapshot
5.2. Global Ocular Drug Delivery Market by Technology, Performance - Potential Analysis
5.3. Global Ocular Drug Delivery Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
5.4. Ocular Drug Delivery Market, Sub Segment Analysis
5.4.1. Topical
5.4.2. Iontophoresis
5.4.3. Ocular Insert
5.4.4. Intraocular Implants
5.4.5. In Situ Gel Punctal Plugs
5.4.6. Others
CHAPTER 6. GLOBAL OCULAR DRUG DELIVERY MARKET, BY FORMULATION TYPE
6.1. Market Snapshot
6.2. Global Ocular Drug Delivery Market by Formulation Type, Performance - Potential Analysis
6.3. Global Ocular Drug Delivery Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
6.4. Ocular Drug Delivery Market, Sub Segment Analysis
6.4.1. Liposomes & Nanoparticles
6.4.2. Solution
6.4.3. Emulsion
6.4.4. Suspension
6.4.5. Ointment
CHAPTER 7. GLOBAL OCULAR DRUG DELIVERY MARKET, BY DISEASE TYPE
7.1. Market Snapshot
7.2. Global Ocular Drug Delivery Market by Disease Type, Performance - Potential Analysis
7.3. Global Ocular Drug Delivery Market Estimates & Forecasts by Disease Type 2020-2030 (USD Billion)
7.4. Ocular Drug Delivery Market, Sub Segment Analysis
7.4.1. Glaucoma
7.4.2. Diabetic Retinopathy
7.4.3. Dry Eye Syndrome
7.4.4. Macular Degeneration
7.4.5. Cataract
7.4.6. Others
CHAPTER 8. GLOBAL OCULAR DRUG DELIVERY MARKET, BY END USER
8.1. Market Snapshot
8.2. Global Ocular Drug Delivery Market by End User, Performance - Potential Analysis
8.3. Global Ocular Drug Delivery Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
8.4. Ocular Drug Delivery Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Ophthalmic Clinics
8.4.3. Ambulatory Surgical Centers
8.4.4. Homecare Settings
CHAPTER 9. GLOBAL OCULAR DRUG DELIVERY MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Ocular Drug Delivery Market, Regional Market Snapshot
9.4. North America Ocular Drug Delivery Market
9.4.1. U.S. Ocular Drug Delivery Market
9.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.2. Formulation Type breakdown estimates & forecasts, 2020-2030
9.4.1.3. Disease Type breakdown estimates & forecasts, 2020-2030
9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Ocular Drug Delivery Market
9.5. Europe Ocular Drug Delivery Market Snapshot
9.5.1. U.K. Ocular Drug Delivery Market
9.5.2. Germany Ocular Drug Delivery Market
9.5.3. France Ocular Drug Delivery Market
9.5.4. Spain Ocular Drug Delivery Market
9.5.5. Italy Ocular Drug Delivery Market
9.5.6. Rest of Europe Ocular Drug Delivery Market
9.6. Asia-Pacific Ocular Drug Delivery Market Snapshot
9.6.1. China Ocular Drug Delivery Market
9.6.2. India Ocular Drug Delivery Market
9.6.3. Japan Ocular Drug Delivery Market
9.6.4. Australia Ocular Drug Delivery Market
9.6.5. South Korea Ocular Drug Delivery Market
9.6.6. Rest of Asia Pacific Ocular Drug Delivery Market
9.7. Latin America Ocular Drug Delivery Market Snapshot
9.7.1. Brazil Ocular Drug Delivery Market
9.7.2. Mexico Ocular Drug Delivery Market
9.8. Middle East & Africa Ocular Drug Delivery Market
9.8.1. Saudi Arabia Ocular Drug Delivery Market
9.8.2. South Africa Ocular Drug Delivery Market
9.8.3. Rest of Middle East & Africa Ocular Drug Delivery Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Valeant Pharmaceuticals International, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Taiwan Liposome Company, Ltd.
10.3.3. Ocular Therapeutix, Inc.
10.3.4. Graybug Vision Inc.
10.3.5. EyeGate Pharma
10.3.6. Clearside Biomedical, Inc.
10.3.7. Alimera Sciences
10.3.8. Envisia Therapeutics
10.3.9. Allergan, Plc.
10.3.10. AbbVie Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Ocular Drug Delivery Market, report scope
TABLE 2. Global Ocular Drug Delivery Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Ocular Drug Delivery Market estimates & forecasts by Technology 2020-2030 (USD Billion)
TABLE 4. Global Ocular Drug Delivery Market estimates & forecasts by Formulation Type 2020-2030 (USD Billion)
TABLE 5. Global Ocular Drug Delivery Market estimates & forecasts by Disease Type 2020-2030 (USD Billion)
TABLE 6. Global Ocular Drug Delivery Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 7. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Ocular Drug Delivery Market
TABLE 72. List of primary sources, used in the study of global Ocular Drug Delivery Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Ocular Drug Delivery Market, report scope
TABLE 2. Global Ocular Drug Delivery Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Ocular Drug Delivery Market estimates & forecasts by Technology 2020-2030 (USD Billion)
TABLE 4. Global Ocular Drug Delivery Market estimates & forecasts by Formulation Type 2020-2030 (USD Billion)
TABLE 5. Global Ocular Drug Delivery Market estimates & forecasts by Disease Type 2020-2030 (USD Billion)
TABLE 6. Global Ocular Drug Delivery Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 7. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Ocular Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Ocular Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Ocular Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Ocular Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Ocular Drug Delivery Market
TABLE 72. List of primary sources, used in the study of global Ocular Drug Delivery Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Ocular Drug Delivery Market, research methodology
FIG 2. Global Ocular Drug Delivery Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Ocular Drug Delivery Market, key trends 2022
FIG 5. Global Ocular Drug Delivery Market, growth prospects 2023-2030
FIG 6. Global Ocular Drug Delivery Market, porters 5 force model
FIG 7. Global Ocular Drug Delivery Market, pest analysis
FIG 8. Global Ocular Drug Delivery Market, value chain analysis
FIG 9. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Ocular Drug Delivery Market, regional snapshot 2020 & 2030
FIG 15. North America Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 16. Europe Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Ocular Drug Delivery Market, research methodology
FIG 2. Global Ocular Drug Delivery Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Ocular Drug Delivery Market, key trends 2022
FIG 5. Global Ocular Drug Delivery Market, growth prospects 2023-2030
FIG 6. Global Ocular Drug Delivery Market, porters 5 force model
FIG 7. Global Ocular Drug Delivery Market, pest analysis
FIG 8. Global Ocular Drug Delivery Market, value chain analysis
FIG 9. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Ocular Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Ocular Drug Delivery Market, regional snapshot 2020 & 2030
FIG 15. North America Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 16. Europe Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Ocular Drug Delivery Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
